The biotechnology company Bio-Works has appointed its nomination committee ahead of the 2026 Annual General Meeting. This is stated in a press release. The nomination committee consists of: * Elisabet Tunon, appointed by Swedia Invest * Erik Åfors, appointed by Calyptra* Jonas Ahlén, appointed by Bonit InvestCompared to last year's nomination committee, Bonit Invest has joined this year while Karkas Capital has left. Bonit Invest is a company controlled by Laurent Leksell, who is the principal owner of the medical technology company Elekta.